Home > Insider Trading > Filing (0001127602-18-004003)

Filing Details

Accession Number:: 0001127602-18-004003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-05 16:35:40
Reporting Period:: 2018-02-01

Accepted Time:: 2018-02-05 16:35:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1156039	Anthem Inc.	ANTM	Hospital & Medical Service Plans (6324)	352145715

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1179745	Joseph Swedish	120 Monument Circle Indianapolis IN 46204	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-02-01	17,803	$67.44	84,346	No	4	M	Direct
Common Stock	Acquisiton	2018-02-01	46,600	$89.44	130,946	No	4	M	Direct
Common Stock	Disposition	2018-02-01	6,800	$242.40	124,146	No	4	S	Direct
Common Stock	Disposition	2018-02-01	19,100	$243.82	105,046	No	4	S	Direct
Common Stock	Disposition	2018-02-01	26,703	$244.52	78,343	No	4	S	Direct
Common Stock	Disposition	2018-02-01	8,900	$245.71	69,443	No	4	S	Direct
Common Stock	Disposition	2018-02-01	1,900	$246.69	67,543	No	4	S	Direct
Common Stock	Disposition	2018-02-01	1,000	$247.73	66,543	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-02-01	17,803	$0.00	17,803	$67.44
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-02-01	46,600	$0.00	46,600	$89.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-04-01	No	4	M	Direct
0		2021-03-03	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2017, as modified on December 11, 2017.
This transaction was executed in multiple trades at prices ranging from $241.96 to $242.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $243.18 to $244.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $244.18 to $245.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $245.24 to $246.20. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $246.36 to $246.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $247.62 to $247.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option represents a right to purchase a total of 102,303 shares, and is exercisable in six semi-annual installments, with three installments of 17,050 shares and three installments of 17,051 shares each, beginning on October 1, 2013, which is the six-month anniversary of the option grant date.
The option represents a right to purchase a total of 114,100 shares, and is exercisable in six semi-annual installments, with two installments of 19,016 shares and four installments of 19,017 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.